Results 71 to 80 of about 9,952 (205)

Treatment of Reactive Histiocytosis With Oclacitinib: A Retrospective Case Series of 10 Dogs

open access: yesVeterinary Dermatology, Volume 37, Issue 3, Page 419-426, June 2026.
Background: Canine reactive histiocytosis is a proliferative disorder of activated interstitial dendritic cells with cutaneous and systemic forms. An immune‐mediated aetiology is likely, and systemic immunomodulatory agents such as corticosteroids, tetracycline/niacinamide, ciclosporin, azathioprine and leflunomide have been employed for its management.
Christine L. Cain   +2 more
wiley   +1 more source

A importância das provas epicutâneas de contacto no diagnóstico diferencial de reações a medicamentos The importance of patch tests in the differential diagnosis of adverse drug reactions

open access: yesAnais Brasileiros de Dermatologia, 2011
O eritema exsudativo multiforme é uma erupção aguda, autolimitada, frequentemente associada a infecções (geralmente virais), doenças sistêmicas e fármacos.
Ana Rita Travassos   +5 more
doaj   +1 more source

Prevention of recurrent erythema multiforme with lenalidomide: a case series

open access: yes, 2023
International audiencePrevention of recurrences of erythema multiforme is a therapeutic challenge. Thalidomide is effective, but its use is limited by adverse effects, especially peripheral neuropathy.
Joly, Pascal   +7 more
core   +1 more source

Apoptosis in oral erythema multiforme

open access: yes, 1997
Objective. Cell death was evaluated in oral erythema multiforme to test the hypothesis that apoptosis may be a mechanism by which keratinocytes die in this condition. Study design.
Dekker, N.P.   +4 more
core  

Photodistributed Erythema Multiforme

open access: yesActas Dermo-Sifiliográficas (English Edition), 2013
Although the existence of photodistributed erythema multiforme has been recognized for years, few cases have been described to date. It is an uncommon, and probably underdiagnosed, skin disorder that can affect individuals of both sexes and all ages.
L, Rodríguez-Pazos   +3 more
openaire   +2 more sources

Sorafenib-induced erythema multiforme in metastatic renal cell carcinoma

open access: yes, 2009
Sorafenib is a new therapeutic agent being used in metastatic renal cell carcinoma, hepatocellular carcinoma, and malignant melanoma. The most frequently seen cutaneous side effects due to sorafenib are erythema, exfoliative dermatitis, acne vulgaris ...
Temeltaş G.   +6 more
core   +1 more source

Apremilast for treatment of recurrent erythema multiforme [PDF]

open access: yes, 2017
Recurrent erythema multiforme with oralinvolvement is therapeutically challenging.Apremilast has been used with success in resolvingthe oral aphthae of Behçet disease, prompting theuse of the drug in patients with oral erosions fromerythema multiforme ...
Levitt, Jacob   +2 more
core   +1 more source

Recurrent Erythema Multiforme Induced by the Combination of Pembrolizumab and Radiation

open access: yes, 2021
Erythema multiforme is a self-limited condition that is characterized by the rapid onset of symmetric targetoid lesions. This hypersensitivity reaction is commonly triggered by herpes simplex virus and Mycoplasma pneumoniae infections.
Nathoo, Rajiv   +2 more
core   +1 more source

Urticaria multiforme is a variation of urticaria, which imitates erythema multiforme.

open access: yes, 2013
A 21-month-old boy developed urticaria multiforme during the course of a presumed pneumonia, which was treated with imacillin. At admission to hospital he was initially considered to have erythema multiforme, but the correct diagnosis was soon ...
Bracher, Linda   +2 more
core   +1 more source

Erythema multiforme: A case report

open access: yesJournal of Indian Academy of Oral Medicine and Radiology, 2017
Erythema multiforme (EM) is a life threatening mucocutaneous disorder where early diagnosis and management is of utmost important. Among various etiological agents, viral etiology is the most common and is characterized by ulcerations, erosions, and ...
Arutla Rashmitha   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy